Brazilian CDMO IdeeLab unpacks the necessary steps for taking ag biologicals from molecules to markets around the world.
More detailed information regarding these and other risks and uncertainties is included under the heading “Risk Factors” in the Company’s Annual Report on Form 20-F filed with the U.S. Securities and ...
Due to the impact of portfolio rationalization, and considering the challenging business environment, the company expects a ...
ESTEVE CDMO, a global CDMO specializing in high-quality small-molecule APIs and pharmaceutical intermediates, began a $15.5 ...
For CDMOs that partner with companies on a tech transfer, the process may be familiar but nevertheless daunting.
CordenPharma Colorado is leasing 5505 Central, a newly completed, purpose-built peptide development lab at Flatiron Park in Boulder (US). Photo credit: CordenPharma Photo ...
Acting, At-Home Treatment for Inflammatory Acne Lesions to be Administered with the ClearPen™, its Proprietary Intradermal ...
Opportunities lie in tech innovation, patient-centric solutions, strategic partnerships, diversified supply chains, and adapting to regulatory and clinical shifts to enhance market presence.
As CROs and CDMOs expand their role in biopharma development and manufacturing, fast, accurate bioanalytic technologies remain critical to biotherapeutic affordability ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results